Method of detecting mutations associated with thrombosis
First Claim
Patent Images
1. A method for detecting in a nucleic acid sample the presence or absence of at least two variant nucleotides associated with thrombosis, the method comprising the steps of:
- a) amplifying from the sample regions of DNA that include at least two selected nucleotide positions for which variants are known to be associated with thrombosis, to form amplified DNA products;
b) hybridizing at least two tagged allele specific extension primers to a complementary target sequence in the amplified DNA products, wherein each tagged allele specific extension primer has a 3′
-end hybridizing portion capable of hybridizing to the corresponding amplified DNA, and wherein the 3′
end hybridizing portions of the at least two tagged allele specific extension primers each comprise a sequence selected from the group consisting of bases from position 25 to the 3′
terminal nucleotide of SEQ ID NO;
1 to SEQ ID NO;
12, and a 5′
-end tag portion complementary to a corresponding anti-tag sequence, the terminal nucleotide of the 3′
end hybridizing portion being either complementary to a suspected variant nucleotide or to the corresponding wild type nucleotide;
c) extending the at least two tagged allele specific extension primers, using labelled nucleotides, if the terminal nucleotide of each 3′
end hybridizing portion is a perfect match to the corresponding amplified DNA product; and
d) hybridizing the at least two tagged allele specific extension primers to their corresponding anti-tag sequences and detecting the presence of labelled extension products.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides a method for the simultaneous identification of two or more single base changes in a plurality of target nucleotide sequences that are markers associated with cardiovascular diseases such as deep vein thrombosis and the like. Multiplex detection is accomplished using multiplexed tagged allele specific primer extension (ASPE) and hybridization of such extended primers to a probe, preferably an addressable anti-tagged support
11 Citations
22 Claims
-
1. A method for detecting in a nucleic acid sample the presence or absence of at least two variant nucleotides associated with thrombosis, the method comprising the steps of:
-
a) amplifying from the sample regions of DNA that include at least two selected nucleotide positions for which variants are known to be associated with thrombosis, to form amplified DNA products;
b) hybridizing at least two tagged allele specific extension primers to a complementary target sequence in the amplified DNA products, wherein each tagged allele specific extension primer has a 3′
-end hybridizing portion capable of hybridizing to the corresponding amplified DNA, and wherein the 3′
end hybridizing portions of the at least two tagged allele specific extension primers each comprise a sequence selected from the group consisting of bases from position 25 to the 3′
terminal nucleotide of SEQ ID NO;
1 to SEQ ID NO;
12, and a 5′
-end tag portion complementary to a corresponding anti-tag sequence, the terminal nucleotide of the 3′
end hybridizing portion being either complementary to a suspected variant nucleotide or to the corresponding wild type nucleotide;
c) extending the at least two tagged allele specific extension primers, using labelled nucleotides, if the terminal nucleotide of each 3′
end hybridizing portion is a perfect match to the corresponding amplified DNA product; and
d) hybridizing the at least two tagged allele specific extension primers to their corresponding anti-tag sequences and detecting the presence of labelled extension products. - View Dependent Claims (2, 3, 4, 5)
-
-
6. A method for detecting in a nucleic acid sample the presence or absence of at least two variant nucleotides associated with thrombosis, the method comprising the steps of;
-
a) amplifying from the sample regions of DNA that include at least two selected nucleotide positions for which variants are known to be associated with thrombosis to form amplified DNA products;
b) hybridizing at least two tagged allele specific extension primers to a complementary target sequence in the amplified DNA products, wherein the at least two tagged allele-specific extension primers are selected from the group consisting of SEQ ID NO;
1 to SEQ ID NO;
12, each tagged allele specific extension primer having a 3′
-end hybridizing portion capable of hybridizing to the corresponding amplified DNA, and a 5′
-end tag portion complementary to a corresponding anti-tag sequence, the terminal nucleotide of the 3′
end hybridizing portion being either complementary to a suspected variant nucleotide or to the corresponding wild type nucleotide;
c) extending the at least two tagged allele specific extension primers, using labelled nucleotides, if the terminal nucleotide of each 3′
end hybridizing portion is a perfect match to the corresponding amplified DNA product;
d) hybridizing the at least two tagged allele specific extension primers to their corresponding anti-tag sequences and detecting the presence of labelled extension products. - View Dependent Claims (7, 8, 9)
-
-
10. A kit for use in detecting in a nucleic acid sample the presence or absence of at least two variant nucleotides associated with thrombosis, said kit comprising a set of at least two tagged allele specific extension primers wherein each tagged allele specific extension primer has a 3′
- -end hybridizing portion including a 3′
terminal nucleotide being either complementary to a variant nucleotide known to be associated with thrombosis or to the corresponding wild type nucleotide and a 5′
-end tag portion complementary to a corresponding anti-tag sequence, and wherein the at least two tagged allele-specific extension primers are selected from the group consisting of SEQ ID NO;
1 to SEQ ID NO;
12. - View Dependent Claims (11, 12, 13)
- -end hybridizing portion including a 3′
-
14-15. -15. (canceled)
-
16. A composition comprising a plurality of polynucleotide primers for use in detecting the presence or absence of variant nucleotides associated with thrombosis, wherein the plurality of primers comprises oligonucleotides having sequences set forth by position 25 to the 3′
- terminal nucleotide of SEQ ID NOs;
1-12, or the complete complements thereof. - View Dependent Claims (17, 18, 19, 20, 21)
- terminal nucleotide of SEQ ID NOs;
-
22. An improved method of simultaneously detecting in a sample the presence or absence of variant nucleotides associated with thrombosis, wherein the improvement comprises simultaneously identifying the presence or absence of variant nucleotides associated with thrombosis via allele specific primer extension using a set of primers having the sequences set forth in SEQ ID NOs:
- 1-12.
Specification